nodes	percent_of_prediction	percent_of_DWPC	metapath
Amiloride—hypertension—metabolic syndrome X	0.726	1	CtDrD
Amiloride—SLC22A2—Metformin—metabolic syndrome X	0.0871	0.535	CbGbCtD
Amiloride—SLC22A1—Metformin—metabolic syndrome X	0.0757	0.465	CbGbCtD
Amiloride—PLAU—endothelium—metabolic syndrome X	0.00531	0.109	CbGeAlD
Amiloride—PLAU—blood vessel—metabolic syndrome X	0.0049	0.101	CbGeAlD
Amiloride—SCNN1G—kidney—metabolic syndrome X	0.0024	0.0494	CbGeAlD
Amiloride—AOC1—kidney—metabolic syndrome X	0.00235	0.0485	CbGeAlD
Amiloride—SLC9A1—cardiovascular system—metabolic syndrome X	0.0023	0.0475	CbGeAlD
Amiloride—SLC9A1—kidney—metabolic syndrome X	0.00225	0.0464	CbGeAlD
Amiloride—PLAU—cardiovascular system—metabolic syndrome X	0.00218	0.045	CbGeAlD
Amiloride—PLAU—kidney—metabolic syndrome X	0.00214	0.044	CbGeAlD
Amiloride—ASIC1—adipose tissue—metabolic syndrome X	0.00212	0.0437	CbGeAlD
Amiloride—SLC9A1—adipose tissue—metabolic syndrome X	0.00203	0.0419	CbGeAlD
Amiloride—SCNN1B—kidney—metabolic syndrome X	0.00203	0.0417	CbGeAlD
Amiloride—PLAU—adipose tissue—metabolic syndrome X	0.00193	0.0397	CbGeAlD
Amiloride—SCNN1A—kidney—metabolic syndrome X	0.00187	0.0386	CbGeAlD
Amiloride—SCNN1B—adipose tissue—metabolic syndrome X	0.00183	0.0376	CbGeAlD
Amiloride—SCNN1A—adipose tissue—metabolic syndrome X	0.00169	0.0348	CbGeAlD
Amiloride—SCNN1D—liver—metabolic syndrome X	0.00152	0.0312	CbGeAlD
Amiloride—AOC1—liver—metabolic syndrome X	0.00149	0.0307	CbGeAlD
Amiloride—SLC9A1—liver—metabolic syndrome X	0.00143	0.0294	CbGeAlD
Amiloride—PLAU—liver—metabolic syndrome X	0.00135	0.0278	CbGeAlD
Amiloride—SCNN1A—liver—metabolic syndrome X	0.00118	0.0244	CbGeAlD
Amiloride—SLC22A2—kidney—metabolic syndrome X	0.00101	0.0208	CbGeAlD
Amiloride—Heartburn—Metformin—metabolic syndrome X	0.00078	0.1	CcSEcCtD
Amiloride—SLC22A4—kidney—metabolic syndrome X	0.00075	0.0154	CbGeAlD
Amiloride—SLC22A1—kidney—metabolic syndrome X	0.000714	0.0147	CbGeAlD
Amiloride—SLC22A4—adipose tissue—metabolic syndrome X	0.000676	0.0139	CbGeAlD
Amiloride—SLC22A1—adipose tissue—metabolic syndrome X	0.000644	0.0133	CbGeAlD
Amiloride—SLC22A1—liver—metabolic syndrome X	0.000451	0.0093	CbGeAlD
Amiloride—Nasal congestion—Metformin—metabolic syndrome X	0.000428	0.0551	CcSEcCtD
Amiloride—Pain in extremity—Metformin—metabolic syndrome X	0.00039	0.0502	CcSEcCtD
Amiloride—Cramp muscle—Metformin—metabolic syndrome X	0.000351	0.0452	CcSEcCtD
Amiloride—Abdominal distension—Metformin—metabolic syndrome X	0.000339	0.0436	CcSEcCtD
Amiloride—Angina pectoris—Metformin—metabolic syndrome X	0.000328	0.0422	CcSEcCtD
Amiloride—Neutropenia—Metformin—metabolic syndrome X	0.000315	0.0405	CcSEcCtD
Amiloride—Bradycardia—Metformin—metabolic syndrome X	0.000275	0.0353	CcSEcCtD
Amiloride—Flatulence—Metformin—metabolic syndrome X	0.000231	0.0298	CcSEcCtD
Amiloride—PLAU—Endochondral Ossification—TGFB1—metabolic syndrome X	0.000226	0.00412	CbGpPWpGaD
Amiloride—Muscle spasms—Metformin—metabolic syndrome X	0.000226	0.029	CcSEcCtD
Amiloride—Tremor—Metformin—metabolic syndrome X	0.00022	0.0283	CcSEcCtD
Amiloride—PLAU—AP-1 transcription factor network—TGFB1—metabolic syndrome X	0.00021	0.00384	CbGpPWpGaD
Amiloride—ASIC2—Transmembrane transport of small molecules—APOB—metabolic syndrome X	0.000209	0.00382	CbGpPWpGaD
Amiloride—Palpitations—Metformin—metabolic syndrome X	0.000207	0.0267	CcSEcCtD
Amiloride—SLC9A1—Transmembrane transport of small molecules—GCKR—metabolic syndrome X	0.000206	0.00376	CbGpPWpGaD
Amiloride—Chest pain—Metformin—metabolic syndrome X	0.0002	0.0257	CcSEcCtD
Amiloride—SCNN1B—Transmembrane transport of small molecules—SLC2A4—metabolic syndrome X	0.000193	0.00352	CbGpPWpGaD
Amiloride—ASIC1—Transmembrane transport of small molecules—SLC2A4—metabolic syndrome X	0.000193	0.00352	CbGpPWpGaD
Amiloride—SCNN1G—Transmembrane transport of small molecules—SLC2A4—metabolic syndrome X	0.000193	0.00352	CbGpPWpGaD
Amiloride—SCNN1D—Transmembrane transport of small molecules—SLC2A4—metabolic syndrome X	0.000193	0.00352	CbGpPWpGaD
Amiloride—SCNN1A—Transmembrane transport of small molecules—SLC2A4—metabolic syndrome X	0.000193	0.00352	CbGpPWpGaD
Amiloride—Shock—Metformin—metabolic syndrome X	0.000188	0.0243	CcSEcCtD
Amiloride—SLC22A4—SLC-mediated transmembrane transport—GCKR—metabolic syndrome X	0.000186	0.00338	CbGpPWpGaD
Amiloride—Anorexia—Metformin—metabolic syndrome X	0.000183	0.0235	CcSEcCtD
Amiloride—PLAU—ATF-2 transcription factor network—IL6—metabolic syndrome X	0.000182	0.00332	CbGpPWpGaD
Amiloride—PLAU—FGF signaling pathway—AKT1—metabolic syndrome X	0.00018	0.00328	CbGpPWpGaD
Amiloride—ASIC2—Transmembrane transport of small molecules—PPARA—metabolic syndrome X	0.000177	0.00322	CbGpPWpGaD
Amiloride—SLC9A1—Endothelins—AKT1—metabolic syndrome X	0.000176	0.00322	CbGpPWpGaD
Amiloride—Musculoskeletal discomfort—Metformin—metabolic syndrome X	0.000175	0.0225	CcSEcCtD
Amiloride—Paraesthesia—Metformin—metabolic syndrome X	0.000172	0.0221	CcSEcCtD
Amiloride—Dyspnoea—Metformin—metabolic syndrome X	0.000171	0.022	CcSEcCtD
Amiloride—Somnolence—Metformin—metabolic syndrome X	0.00017	0.0219	CcSEcCtD
Amiloride—Dyspepsia—Metformin—metabolic syndrome X	0.000169	0.0217	CcSEcCtD
Amiloride—SLC9A1—Disease—G6PC2—metabolic syndrome X	0.000168	0.00307	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—FMO3—metabolic syndrome X	0.000168	0.00307	CbGpPWpGaD
Amiloride—Decreased appetite—Metformin—metabolic syndrome X	0.000167	0.0214	CcSEcCtD
Amiloride—ASIC2—Transmembrane transport of small molecules—APOA1—metabolic syndrome X	0.000166	0.00302	CbGpPWpGaD
Amiloride—Gastrointestinal disorder—Metformin—metabolic syndrome X	0.000165	0.0213	CcSEcCtD
Amiloride—Fatigue—Metformin—metabolic syndrome X	0.000165	0.0213	CcSEcCtD
Amiloride—Constipation—Metformin—metabolic syndrome X	0.000164	0.0211	CcSEcCtD
Amiloride—SLC9A1—Transmembrane transport of small molecules—GCK—metabolic syndrome X	0.000164	0.00299	CbGpPWpGaD
Amiloride—SCNN1D—Transmembrane transport of small molecules—APOB—metabolic syndrome X	0.000159	0.00289	CbGpPWpGaD
Amiloride—SCNN1A—Transmembrane transport of small molecules—APOB—metabolic syndrome X	0.000159	0.00289	CbGpPWpGaD
Amiloride—SCNN1G—Transmembrane transport of small molecules—APOB—metabolic syndrome X	0.000159	0.00289	CbGpPWpGaD
Amiloride—ASIC1—Transmembrane transport of small molecules—APOB—metabolic syndrome X	0.000159	0.00289	CbGpPWpGaD
Amiloride—SCNN1B—Transmembrane transport of small molecules—APOB—metabolic syndrome X	0.000159	0.00289	CbGpPWpGaD
Amiloride—PLAU—AP-1 transcription factor network—IL6—metabolic syndrome X	0.000159	0.00289	CbGpPWpGaD
Amiloride—SLC9A1—Transmembrane transport of small molecules—CETP—metabolic syndrome X	0.000158	0.00288	CbGpPWpGaD
Amiloride—Feeling abnormal—Metformin—metabolic syndrome X	0.000158	0.0203	CcSEcCtD
Amiloride—PLAU—Endochondral Ossification—AKT1—metabolic syndrome X	0.000157	0.00287	CbGpPWpGaD
Amiloride—Gastrointestinal pain—Metformin—metabolic syndrome X	0.000157	0.0202	CcSEcCtD
Amiloride—PLAU—Senescence and Autophagy in Cancer—TGFB1—metabolic syndrome X	0.000152	0.00277	CbGpPWpGaD
Amiloride—Abdominal pain—Metformin—metabolic syndrome X	0.000151	0.0195	CcSEcCtD
Amiloride—SLC9A1—Metabolism—EPHX2—metabolic syndrome X	0.00015	0.00273	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—MLXIPL—metabolic syndrome X	0.00015	0.00273	CbGpPWpGaD
Amiloride—PLAU—DNA Damage Response (only ATM dependent)—TGFB1—metabolic syndrome X	0.000148	0.00269	CbGpPWpGaD
Amiloride—SLC22A4—SLC-mediated transmembrane transport—GCK—metabolic syndrome X	0.000147	0.00269	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—G6PC2—metabolic syndrome X	0.000141	0.00257	CbGpPWpGaD
Amiloride—SLC22A4—Transmembrane transport of small molecules—G6PC2—metabolic syndrome X	0.000138	0.00251	CbGpPWpGaD
Amiloride—Asthenia—Metformin—metabolic syndrome X	0.000137	0.0177	CcSEcCtD
Amiloride—Pruritus—Metformin—metabolic syndrome X	0.000136	0.0174	CcSEcCtD
Amiloride—SCNN1G—Transmembrane transport of small molecules—PPARA—metabolic syndrome X	0.000134	0.00244	CbGpPWpGaD
Amiloride—SCNN1A—Transmembrane transport of small molecules—PPARA—metabolic syndrome X	0.000134	0.00244	CbGpPWpGaD
Amiloride—SCNN1B—Transmembrane transport of small molecules—PPARA—metabolic syndrome X	0.000134	0.00244	CbGpPWpGaD
Amiloride—SCNN1D—Transmembrane transport of small molecules—PPARA—metabolic syndrome X	0.000134	0.00244	CbGpPWpGaD
Amiloride—ASIC1—Transmembrane transport of small molecules—PPARA—metabolic syndrome X	0.000134	0.00244	CbGpPWpGaD
Amiloride—ASIC2—Transmembrane transport of small molecules—ALB—metabolic syndrome X	0.000131	0.00239	CbGpPWpGaD
Amiloride—Diarrhoea—Metformin—metabolic syndrome X	0.000131	0.0169	CcSEcCtD
Amiloride—SLC9A1—SLC-mediated transmembrane transport—ALB—metabolic syndrome X	0.000129	0.00235	CbGpPWpGaD
Amiloride—SLC22A2—SLC-mediated transmembrane transport—G6PC2—metabolic syndrome X	0.000128	0.00234	CbGpPWpGaD
Amiloride—SLC9A1—Transmembrane transport of small molecules—SLC2A4—metabolic syndrome X	0.000127	0.00232	CbGpPWpGaD
Amiloride—Dizziness—Metformin—metabolic syndrome X	0.000127	0.0163	CcSEcCtD
Amiloride—SCNN1A—Transmembrane transport of small molecules—APOA1—metabolic syndrome X	0.000126	0.00229	CbGpPWpGaD
Amiloride—SCNN1D—Transmembrane transport of small molecules—APOA1—metabolic syndrome X	0.000126	0.00229	CbGpPWpGaD
Amiloride—ASIC1—Transmembrane transport of small molecules—APOA1—metabolic syndrome X	0.000126	0.00229	CbGpPWpGaD
Amiloride—SCNN1G—Transmembrane transport of small molecules—APOA1—metabolic syndrome X	0.000126	0.00229	CbGpPWpGaD
Amiloride—SCNN1B—Transmembrane transport of small molecules—APOA1—metabolic syndrome X	0.000126	0.00229	CbGpPWpGaD
Amiloride—Vomiting—Metformin—metabolic syndrome X	0.000122	0.0157	CcSEcCtD
Amiloride—Rash—Metformin—metabolic syndrome X	0.000121	0.0155	CcSEcCtD
Amiloride—SLC9A1—Disease—G6PD—metabolic syndrome X	0.000121	0.0022	CbGpPWpGaD
Amiloride—Dermatitis—Metformin—metabolic syndrome X	0.000121	0.0155	CcSEcCtD
Amiloride—Headache—Metformin—metabolic syndrome X	0.00012	0.0154	CcSEcCtD
Amiloride—SLC9A1—Metabolism—FABP4—metabolic syndrome X	0.00012	0.00218	CbGpPWpGaD
Amiloride—SLC22A1—SLC-mediated transmembrane transport—G6PC2—metabolic syndrome X	0.000119	0.00218	CbGpPWpGaD
Amiloride—SLC22A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A4—metabolic syndrome X	0.000119	0.00218	CbGpPWpGaD
Amiloride—SLC9A1—Disease—HDAC3—metabolic syndrome X	0.000118	0.00215	CbGpPWpGaD
Amiloride—SLC9A1—ErbB1 downstream signaling—AKT1—metabolic syndrome X	0.000117	0.00214	CbGpPWpGaD
Amiloride—SLC9A1—Disease—GCKR—metabolic syndrome X	0.000115	0.0021	CbGpPWpGaD
Amiloride—SLC22A4—SLC-mediated transmembrane transport—SLC2A4—metabolic syndrome X	0.000115	0.00209	CbGpPWpGaD
Amiloride—PLAU—Senescence and Autophagy in Cancer—IL6—metabolic syndrome X	0.000115	0.00209	CbGpPWpGaD
Amiloride—Nausea—Metformin—metabolic syndrome X	0.000114	0.0146	CcSEcCtD
Amiloride—SLC9A1—Metabolism—HSD11B1—metabolic syndrome X	0.000113	0.00207	CbGpPWpGaD
Amiloride—PLAU—Hemostasis—IGF2—metabolic syndrome X	0.000112	0.00205	CbGpPWpGaD
Amiloride—SLC22A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A4—metabolic syndrome X	0.000111	0.00203	CbGpPWpGaD
Amiloride—PLAU—Hemostasis—APOB—metabolic syndrome X	0.000109	0.00199	CbGpPWpGaD
Amiloride—PLAU—Hemostasis—PLA2G4A—metabolic syndrome X	0.000106	0.00193	CbGpPWpGaD
Amiloride—SLC9A1—Transmembrane transport of small molecules—APOB—metabolic syndrome X	0.000105	0.00191	CbGpPWpGaD
Amiloride—SLC9A1—Disease—TRIB3—metabolic syndrome X	0.000103	0.00187	CbGpPWpGaD
Amiloride—SLC9A1—Disease—RBP4—metabolic syndrome X	0.000103	0.00187	CbGpPWpGaD
Amiloride—PLAU—DNA Damage Response (only ATM dependent)—AKT1—metabolic syndrome X	0.000103	0.00187	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—G6PD—metabolic syndrome X	0.000101	0.00185	CbGpPWpGaD
Amiloride—SCNN1G—Transmembrane transport of small molecules—ALB—metabolic syndrome X	9.95e-05	0.00181	CbGpPWpGaD
Amiloride—ASIC1—Transmembrane transport of small molecules—ALB—metabolic syndrome X	9.95e-05	0.00181	CbGpPWpGaD
Amiloride—SCNN1A—Transmembrane transport of small molecules—ALB—metabolic syndrome X	9.95e-05	0.00181	CbGpPWpGaD
Amiloride—SCNN1B—Transmembrane transport of small molecules—ALB—metabolic syndrome X	9.95e-05	0.00181	CbGpPWpGaD
Amiloride—SCNN1D—Transmembrane transport of small molecules—ALB—metabolic syndrome X	9.95e-05	0.00181	CbGpPWpGaD
Amiloride—PLAU—Hemostasis—CD36—metabolic syndrome X	9.89e-05	0.0018	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—HDAC3—metabolic syndrome X	9.87e-05	0.0018	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—LPA—metabolic syndrome X	9.65e-05	0.00176	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—GCKR—metabolic syndrome X	9.65e-05	0.00176	CbGpPWpGaD
Amiloride—SLC22A4—Transmembrane transport of small molecules—GCKR—metabolic syndrome X	9.43e-05	0.00172	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—PLA2G6—metabolic syndrome X	9.35e-05	0.0017	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—APOA5—metabolic syndrome X	9.25e-05	0.00169	CbGpPWpGaD
Amiloride—SLC9A1—Disease—NAMPT—metabolic syndrome X	9.21e-05	0.00168	CbGpPWpGaD
Amiloride—SLC9A1—Disease—GCK—metabolic syndrome X	9.15e-05	0.00167	CbGpPWpGaD
Amiloride—SLC9A1—Disease—APOC3—metabolic syndrome X	9.1e-05	0.00166	CbGpPWpGaD
Amiloride—SLC9A1—Transmembrane transport of small molecules—PPARA—metabolic syndrome X	8.82e-05	0.00161	CbGpPWpGaD
Amiloride—SLC22A2—SLC-mediated transmembrane transport—GCKR—metabolic syndrome X	8.78e-05	0.0016	CbGpPWpGaD
Amiloride—PLAU—Hemostasis—APOA1—metabolic syndrome X	8.62e-05	0.00157	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—TRIB3—metabolic syndrome X	8.6e-05	0.00157	CbGpPWpGaD
Amiloride—SLC9A1—Disease—HMGA1—metabolic syndrome X	8.37e-05	0.00153	CbGpPWpGaD
Amiloride—SLC9A1—Transmembrane transport of small molecules—APOA1—metabolic syndrome X	8.28e-05	0.00151	CbGpPWpGaD
Amiloride—SLC22A1—SLC-mediated transmembrane transport—GCKR—metabolic syndrome X	8.18e-05	0.00149	CbGpPWpGaD
Amiloride—SLC9A1—Disease—GOT2—metabolic syndrome X	7.99e-05	0.00146	CbGpPWpGaD
Amiloride—SLC9A1—Disease—CYBA—metabolic syndrome X	7.95e-05	0.00145	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—NAMPT—metabolic syndrome X	7.72e-05	0.00141	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—GCK—metabolic syndrome X	7.67e-05	0.0014	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—LIPC—metabolic syndrome X	7.67e-05	0.0014	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—APOC3—metabolic syndrome X	7.62e-05	0.00139	CbGpPWpGaD
Amiloride—SLC22A4—Transmembrane transport of small molecules—GCK—metabolic syndrome X	7.49e-05	0.00137	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—CETP—metabolic syndrome X	7.4e-05	0.00135	CbGpPWpGaD
Amiloride—SLC22A4—Transmembrane transport of small molecules—CETP—metabolic syndrome X	7.23e-05	0.00132	CbGpPWpGaD
Amiloride—PLAU—Hemostasis—IGF1—metabolic syndrome X	7.21e-05	0.00132	CbGpPWpGaD
Amiloride—SLC9A1—Disease—SLC2A4—metabolic syndrome X	7.12e-05	0.0013	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—SCARB1—metabolic syndrome X	7.08e-05	0.00129	CbGpPWpGaD
Amiloride—SLC22A2—SLC-mediated transmembrane transport—GCK—metabolic syndrome X	6.97e-05	0.00127	CbGpPWpGaD
Amiloride—SLC9A1—Disease—GOT1—metabolic syndrome X	6.89e-05	0.00126	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—SREBF1—metabolic syndrome X	6.88e-05	0.00125	CbGpPWpGaD
Amiloride—PLAU—Hemostasis—SERPINE1—metabolic syndrome X	6.85e-05	0.00125	CbGpPWpGaD
Amiloride—PLAU—Hemostasis—ALB—metabolic syndrome X	6.83e-05	0.00125	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—HMGCR—metabolic syndrome X	6.69e-05	0.00122	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—GOT2—metabolic syndrome X	6.69e-05	0.00122	CbGpPWpGaD
Amiloride—SLC9A1—Transmembrane transport of small molecules—ALB—metabolic syndrome X	6.56e-05	0.0012	CbGpPWpGaD
Amiloride—PLAU—Hemostasis—NOS3—metabolic syndrome X	6.54e-05	0.00119	CbGpPWpGaD
Amiloride—SLC22A2—Transmembrane transport of small molecules—G6PC2—metabolic syndrome X	6.51e-05	0.00119	CbGpPWpGaD
Amiloride—SLC22A1—SLC-mediated transmembrane transport—GCK—metabolic syndrome X	6.5e-05	0.00119	CbGpPWpGaD
Amiloride—SLC22A1—Transmembrane transport of small molecules—G6PC2—metabolic syndrome X	6.06e-05	0.00111	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—ABCA1—metabolic syndrome X	5.96e-05	0.00109	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—SLC2A4—metabolic syndrome X	5.96e-05	0.00109	CbGpPWpGaD
Amiloride—SLC22A4—SLC-mediated transmembrane transport—ALB—metabolic syndrome X	5.91e-05	0.00108	CbGpPWpGaD
Amiloride—SLC9A1—Disease—APOB—metabolic syndrome X	5.85e-05	0.00107	CbGpPWpGaD
Amiloride—SLC22A4—Transmembrane transport of small molecules—SLC2A4—metabolic syndrome X	5.83e-05	0.00106	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—GOT1—metabolic syndrome X	5.77e-05	0.00105	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—GGT1—metabolic syndrome X	5.77e-05	0.00105	CbGpPWpGaD
Amiloride—SLC9A1—Disease—LPL—metabolic syndrome X	5.59e-05	0.00102	CbGpPWpGaD
Amiloride—SLC22A2—SLC-mediated transmembrane transport—SLC2A4—metabolic syndrome X	5.42e-05	0.000989	CbGpPWpGaD
Amiloride—SLC22A1—SLC-mediated transmembrane transport—SLC2A4—metabolic syndrome X	5.05e-05	0.000922	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—APOB—metabolic syndrome X	4.9e-05	0.000894	CbGpPWpGaD
Amiloride—SLC22A4—Transmembrane transport of small molecules—APOB—metabolic syndrome X	4.79e-05	0.000873	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—PLA2G4A—metabolic syndrome X	4.77e-05	0.000869	CbGpPWpGaD
Amiloride—SLC9A1—Disease—APOE—metabolic syndrome X	4.68e-05	0.000854	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—LPL—metabolic syndrome X	4.68e-05	0.000853	CbGpPWpGaD
Amiloride—SLC9A1—Disease—APOA1—metabolic syndrome X	4.63e-05	0.000844	CbGpPWpGaD
Amiloride—SLC22A2—Transmembrane transport of small molecules—GCKR—metabolic syndrome X	4.46e-05	0.000814	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—CD36—metabolic syndrome X	4.45e-05	0.000811	CbGpPWpGaD
Amiloride—PLAU—Hemostasis—TGFB1—metabolic syndrome X	4.32e-05	0.000788	CbGpPWpGaD
Amiloride—SLC9A1—Disease—IRS1—metabolic syndrome X	4.18e-05	0.000762	CbGpPWpGaD
Amiloride—SLC22A1—Transmembrane transport of small molecules—GCKR—metabolic syndrome X	4.16e-05	0.000758	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—PPARA—metabolic syndrome X	4.13e-05	0.000754	CbGpPWpGaD
Amiloride—SLC22A4—Transmembrane transport of small molecules—PPARA—metabolic syndrome X	4.04e-05	0.000737	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—AGT—metabolic syndrome X	4e-05	0.00073	CbGpPWpGaD
Amiloride—SLC9A1—Disease—INS—metabolic syndrome X	4e-05	0.00073	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—APOE—metabolic syndrome X	3.92e-05	0.000715	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—APOA1—metabolic syndrome X	3.88e-05	0.000707	CbGpPWpGaD
Amiloride—SLC22A4—Transmembrane transport of small molecules—APOA1—metabolic syndrome X	3.79e-05	0.000691	CbGpPWpGaD
Amiloride—SLC9A1—Disease—SERPINE1—metabolic syndrome X	3.67e-05	0.00067	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—FMO3—metabolic syndrome X	3.64e-05	0.000663	CbGpPWpGaD
Amiloride—SLC22A2—Transmembrane transport of small molecules—GCK—metabolic syndrome X	3.54e-05	0.000646	CbGpPWpGaD
Amiloride—SLC9A1—Disease—NOS3—metabolic syndrome X	3.51e-05	0.00064	CbGpPWpGaD
Amiloride—SLC22A2—Transmembrane transport of small molecules—CETP—metabolic syndrome X	3.42e-05	0.000624	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—PPARG—metabolic syndrome X	3.42e-05	0.000623	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—FMO3—metabolic syndrome X	3.39e-05	0.000618	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—INS—metabolic syndrome X	3.35e-05	0.000611	CbGpPWpGaD
Amiloride—SLC22A1—Transmembrane transport of small molecules—GCK—metabolic syndrome X	3.3e-05	0.000602	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—EPHX2—metabolic syndrome X	3.24e-05	0.000591	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—MLXIPL—metabolic syndrome X	3.24e-05	0.000591	CbGpPWpGaD
Amiloride—SLC9A1—Disease—PTGS2—metabolic syndrome X	3.21e-05	0.000585	CbGpPWpGaD
Amiloride—SLC22A1—Transmembrane transport of small molecules—CETP—metabolic syndrome X	3.19e-05	0.000581	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—ALB—metabolic syndrome X	3.07e-05	0.00056	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—G6PC2—metabolic syndrome X	3.05e-05	0.000556	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—MLXIPL—metabolic syndrome X	3.02e-05	0.000551	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—EPHX2—metabolic syndrome X	3.02e-05	0.000551	CbGpPWpGaD
Amiloride—PLAU—Hemostasis—AKT1—metabolic syndrome X	3e-05	0.000548	CbGpPWpGaD
Amiloride—SLC22A4—Transmembrane transport of small molecules—ALB—metabolic syndrome X	3e-05	0.000547	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—NOS3—metabolic syndrome X	2.94e-05	0.000536	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—G6PC2—metabolic syndrome X	2.84e-05	0.000518	CbGpPWpGaD
Amiloride—SLC22A2—SLC-mediated transmembrane transport—ALB—metabolic syndrome X	2.79e-05	0.00051	CbGpPWpGaD
Amiloride—SLC22A2—Transmembrane transport of small molecules—SLC2A4—metabolic syndrome X	2.76e-05	0.000503	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—PTGS2—metabolic syndrome X	2.69e-05	0.00049	CbGpPWpGaD
Amiloride—SLC22A1—SLC-mediated transmembrane transport—ALB—metabolic syndrome X	2.6e-05	0.000475	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—FABP4—metabolic syndrome X	2.59e-05	0.000473	CbGpPWpGaD
Amiloride—SLC22A1—Transmembrane transport of small molecules—SLC2A4—metabolic syndrome X	2.57e-05	0.000468	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—HSD11B1—metabolic syndrome X	2.46e-05	0.000448	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—FABP4—metabolic syndrome X	2.42e-05	0.000441	CbGpPWpGaD
Amiloride—SLC9A1—Disease—TGFB1—metabolic syndrome X	2.32e-05	0.000423	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—HSD11B1—metabolic syndrome X	2.29e-05	0.000418	CbGpPWpGaD
Amiloride—SLC22A2—Transmembrane transport of small molecules—APOB—metabolic syndrome X	2.26e-05	0.000413	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—G6PD—metabolic syndrome X	2.19e-05	0.000399	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—HDAC3—metabolic syndrome X	2.14e-05	0.00039	CbGpPWpGaD
Amiloride—SLC22A1—Transmembrane transport of small molecules—APOB—metabolic syndrome X	2.11e-05	0.000385	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—LPA—metabolic syndrome X	2.09e-05	0.000381	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—GCKR—metabolic syndrome X	2.09e-05	0.000381	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—G6PD—metabolic syndrome X	2.04e-05	0.000372	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—PLA2G6—metabolic syndrome X	2.02e-05	0.000369	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—APOA5—metabolic syndrome X	2e-05	0.000365	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—HDAC3—metabolic syndrome X	1.99e-05	0.000363	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—LPA—metabolic syndrome X	1.95e-05	0.000355	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—GCKR—metabolic syndrome X	1.95e-05	0.000355	CbGpPWpGaD
Amiloride—SLC22A2—Transmembrane transport of small molecules—PPARA—metabolic syndrome X	1.91e-05	0.000348	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—PLA2G6—metabolic syndrome X	1.89e-05	0.000344	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—APOA5—metabolic syndrome X	1.87e-05	0.00034	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—TRIB3—metabolic syndrome X	1.86e-05	0.00034	CbGpPWpGaD
Amiloride—SLC22A2—Transmembrane transport of small molecules—APOA1—metabolic syndrome X	1.79e-05	0.000327	CbGpPWpGaD
Amiloride—SLC22A1—Transmembrane transport of small molecules—PPARA—metabolic syndrome X	1.78e-05	0.000325	CbGpPWpGaD
Amiloride—SLC9A1—Disease—IL6—metabolic syndrome X	1.75e-05	0.000319	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—TRIB3—metabolic syndrome X	1.74e-05	0.000317	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—NAMPT—metabolic syndrome X	1.67e-05	0.000305	CbGpPWpGaD
Amiloride—SLC22A1—Transmembrane transport of small molecules—APOA1—metabolic syndrome X	1.67e-05	0.000305	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—LIPC—metabolic syndrome X	1.66e-05	0.000303	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—GCK—metabolic syndrome X	1.66e-05	0.000303	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—APOC3—metabolic syndrome X	1.65e-05	0.000301	CbGpPWpGaD
Amiloride—SLC9A1—Disease—AKT1—metabolic syndrome X	1.61e-05	0.000294	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—CETP—metabolic syndrome X	1.6e-05	0.000292	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—NAMPT—metabolic syndrome X	1.56e-05	0.000284	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—LIPC—metabolic syndrome X	1.55e-05	0.000282	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—GCK—metabolic syndrome X	1.55e-05	0.000282	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—APOC3—metabolic syndrome X	1.54e-05	0.00028	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—SCARB1—metabolic syndrome X	1.53e-05	0.00028	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—CETP—metabolic syndrome X	1.49e-05	0.000272	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—SREBF1—metabolic syndrome X	1.49e-05	0.000271	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—HMGCR—metabolic syndrome X	1.45e-05	0.000264	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—GOT2—metabolic syndrome X	1.45e-05	0.000264	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—SCARB1—metabolic syndrome X	1.43e-05	0.000261	CbGpPWpGaD
Amiloride—SLC22A2—Transmembrane transport of small molecules—ALB—metabolic syndrome X	1.42e-05	0.000259	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—SREBF1—metabolic syndrome X	1.39e-05	0.000253	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—AKT1—metabolic syndrome X	1.35e-05	0.000246	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—HMGCR—metabolic syndrome X	1.35e-05	0.000246	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—GOT2—metabolic syndrome X	1.35e-05	0.000246	CbGpPWpGaD
Amiloride—SLC22A1—Transmembrane transport of small molecules—ALB—metabolic syndrome X	1.32e-05	0.000241	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—ABCA1—metabolic syndrome X	1.29e-05	0.000235	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—SLC2A4—metabolic syndrome X	1.29e-05	0.000235	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—GGT1—metabolic syndrome X	1.25e-05	0.000228	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—GOT1—metabolic syndrome X	1.25e-05	0.000228	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—ABCA1—metabolic syndrome X	1.2e-05	0.000219	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—SLC2A4—metabolic syndrome X	1.2e-05	0.000219	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—GGT1—metabolic syndrome X	1.16e-05	0.000212	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—GOT1—metabolic syndrome X	1.16e-05	0.000212	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—APOB—metabolic syndrome X	1.06e-05	0.000193	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—PLA2G4A—metabolic syndrome X	1.03e-05	0.000188	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—LPL—metabolic syndrome X	1.01e-05	0.000185	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—APOB—metabolic syndrome X	9.88e-06	0.00018	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—CD36—metabolic syndrome X	9.62e-06	0.000176	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—PLA2G4A—metabolic syndrome X	9.62e-06	0.000175	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—LPL—metabolic syndrome X	9.44e-06	0.000172	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—CD36—metabolic syndrome X	8.97e-06	0.000164	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—PPARA—metabolic syndrome X	8.94e-06	0.000163	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—AGT—metabolic syndrome X	8.66e-06	0.000158	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—APOE—metabolic syndrome X	8.49e-06	0.000155	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—APOA1—metabolic syndrome X	8.39e-06	0.000153	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—PPARA—metabolic syndrome X	8.34e-06	0.000152	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—AGT—metabolic syndrome X	8.07e-06	0.000147	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—APOE—metabolic syndrome X	7.91e-06	0.000144	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—APOA1—metabolic syndrome X	7.82e-06	0.000143	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—PPARG—metabolic syndrome X	7.39e-06	0.000135	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—INS—metabolic syndrome X	7.25e-06	0.000132	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—PPARG—metabolic syndrome X	6.89e-06	0.000126	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—INS—metabolic syndrome X	6.76e-06	0.000123	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—ALB—metabolic syndrome X	6.65e-06	0.000121	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—NOS3—metabolic syndrome X	6.36e-06	0.000116	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—ALB—metabolic syndrome X	6.2e-06	0.000113	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—NOS3—metabolic syndrome X	5.93e-06	0.000108	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—PTGS2—metabolic syndrome X	5.82e-06	0.000106	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—PTGS2—metabolic syndrome X	5.42e-06	9.89e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—AKT1—metabolic syndrome X	2.92e-06	5.33e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—AKT1—metabolic syndrome X	2.72e-06	4.97e-05	CbGpPWpGaD
